BACKGROUND AND OBJECTIVES: The incidence and prevalence of metabolic acidosis increase with declining kidney function. We studied the associations of both low and high serum bicarbonate levels with all-cause mortality among stage 3 and 4 chronic kidney disease (CKD) patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We examined factors associated with low (<23 mmol/L) and high (>32 mmol/L) serum bicarbonate levels using logistic regression models and associations between bicarbonate and all-cause mortality using Cox-proportional hazard models, Kaplan-Meier survival curves, and time-dependent analysis. RESULTS: Out of 41,749 patients, 13.9% (n = 5796) had low and 1.6% (n = 652) had high serum bicarbonate levels. After adjusting for relevant covariates, there was a significant association between low serum bicarbonate and all-cause mortality (hazard ratio [HR] 1.23, 95% CI 1.16, 1.31). This association was not statistically significant among patients with stage 4 CKD and diabetes. The time-dependent analysis demonstrated a significant mortality risk associated with a decline from normal to low bicarbonate level (HR 1.59, 95% CI 1.49, 1.69). High serum bicarbonate levels were associated with death irrespective of the level of kidney function (HR 1.74, 95% CI 1.52, 2.00). When serum bicarbonate was examined as a continuous variable, a J-shaped relationship was noted between serum bicarbonate and mortality. CONCLUSIONS: Low serum bicarbonate levels are associated with increased mortality among stage 3 CKD patients and patients without diabetes. High serum bicarbonate levels are associated with mortality in both stage 3 and stage 4 CKD patients.
BACKGROUND AND OBJECTIVES: The incidence and prevalence of metabolic acidosis increase with declining kidney function. We studied the associations of both low and high serum bicarbonate levels with all-cause mortality among stage 3 and 4 chronic kidney disease (CKD) patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We examined factors associated with low (<23 mmol/L) and high (>32 mmol/L) serum bicarbonate levels using logistic regression models and associations between bicarbonate and all-cause mortality using Cox-proportional hazard models, Kaplan-Meier survival curves, and time-dependent analysis. RESULTS: Out of 41,749 patients, 13.9% (n = 5796) had low and 1.6% (n = 652) had high serum bicarbonate levels. After adjusting for relevant covariates, there was a significant association between low serum bicarbonate and all-cause mortality (hazard ratio [HR] 1.23, 95% CI 1.16, 1.31). This association was not statistically significant among patients with stage 4 CKD and diabetes. The time-dependent analysis demonstrated a significant mortality risk associated with a decline from normal to low bicarbonate level (HR 1.59, 95% CI 1.49, 1.69). High serum bicarbonate levels were associated with death irrespective of the level of kidney function (HR 1.74, 95% CI 1.52, 2.00). When serum bicarbonate was examined as a continuous variable, a J-shaped relationship was noted between serum bicarbonate and mortality. CONCLUSIONS: Low serum bicarbonate levels are associated with increased mortality among stage 3 CKDpatients and patients without diabetes. High serum bicarbonate levels are associated with mortality in both stage 3 and stage 4 CKDpatients.
Authors: Sankar D Navaneethan; Stacey E Jolly; Jesse D Schold; Susana Arrigain; Welf Saupe; John Sharp; Jennifer Lyons; James F Simon; Martin J Schreiber; Anil Jain; Joseph V Nally Journal: Clin J Am Soc Nephrol Date: 2010-11-04 Impact factor: 8.237
Authors: Warren P Pickering; S Russ Price; Gemma Bircher; Anne C Marinovic; William E Mitch; John Walls Journal: Kidney Int Date: 2002-04 Impact factor: 10.612
Authors: Todd H Driver; Michael G Shlipak; Ronit Katz; Leonard Goldenstein; Mark J Sarnak; Andrew N Hoofnagle; David S Siscovick; Bryan Kestenbaum; Ian H de Boer; Joachim H Ix Journal: Am J Kidney Dis Date: 2014-06-18 Impact factor: 8.860
Authors: Leonard Goldenstein; Todd H Driver; Linda F Fried; Dena E Rifkin; Kushang V Patel; Robert H Yenchek; Tamara B Harris; Stephen B Kritchevsky; Anne B Newman; Mark J Sarnak; Michael G Shlipak; Joachim H Ix Journal: Am J Kidney Dis Date: 2014-06-18 Impact factor: 8.860
Authors: Paul E Drawz; Patrick Archdeacon; Clement J McDonald; Neil R Powe; Kimberly A Smith; Jenna Norton; Desmond E Williams; Uptal D Patel; Andrew Narva Journal: Clin J Am Soc Nephrol Date: 2015-06-25 Impact factor: 8.237
Authors: Marion Vallet; Marie Metzger; Jean-Philippe Haymann; Martin Flamant; Cédric Gauci; Eric Thervet; Jean-Jacques Boffa; François Vrtovsnik; Marc Froissart; Bénédicte Stengel; Pascal Houillier Journal: Kidney Int Date: 2015-03-11 Impact factor: 10.612
Authors: Jessica B Kendrick; Leila Zelnick; Michel B Chonchol; David Siscovick; Andrew N Hoofnagle; Joachim H Ix; Mark Sarnak; Michael G Shlipak; Bryan Kestenbaum; Ian H de Boer Journal: Am J Nephrol Date: 2016-12-10 Impact factor: 3.754